Davita Healthcare Partners Inc (DVA) Stock Price, Quote & News

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 720-631-2100

Website: www.davita.com

Address:

2000 16th Street, Denver, United States

Yamauchii Aug. 24 at 9:22 AM

$AKBA $DVA The Vocal study is officially ON and DaVita/Akebia are recruiting from 17 locations. Probably there is a overlap between Vocal trial and Pilot locations, but the bullish news is lot of Nephros, Nurses, etc are putting hands on the products and they are starting to get familiar with it. Considering we are in mid Q3, I really think we could see good result in terms of revenue for Vafseo this quarter. But looking slightly far on the horizon, Q4 really have the chance to be a monster quarter.

2 · Reply

ExoticDerivativesMgmt Aug. 23 at 11:25 AM

$DVA DaVita Inc is facing dialysis reimbursement pressure and labor cost inflation

0 · Reply

StocktwitsNews Aug. 22 at 3:27 AM

DaVita Under Fire After Cyberattack Compromises 2.7 Million Patients’ Information $DVA https://stocktwits.com/news/equity/markets/da-vita-under-fire-after-cyberattack-compromises-2-7-million-patients-information/chsmo8aRdiC

0 · Reply

TacoDrumpf Aug. 14 at 9:57 PM

$UNH Buffett should have kept some more $DVA Because next...Peoples will soon sell a 2nd kidney !! lol

0 · Reply

TacoDrumpf Aug. 14 at 9:53 PM

$BAC $AAPL $DVA $CHTR Berkshire Hathaway reduced its stake in four holdings, including by size of previous position, Apple (AAPL), DaVita (DVA), Charter Communications (CHTR), and Bank of America (BAC).

1 · Reply

BULLZ820 Aug. 12 at 10:49 PM

$DVA Davita needs to get everyone switched to Vafseo as soon as possible

0 · Reply

StockAutoPro Aug. 12 at 2:43 AM

$DVA: Buy target $127.05 Sell target $135.5 Strong earnings growth potential makes this DVA sector stock a lucrative long-term investment opportunity.

0 · Reply

StockAutoPro Aug. 11 at 5:04 PM

$DVA: Buy target $127.09 Sell target $135.54 Strong earnings report suggests continued growth for this leading biopharmaceutical company.

0 · Reply

NoRallyTil2026 Aug. 7 at 9:35 PM

$LLY $NVO $DVA Surely the struggles of $LLY and $NVO is bullish for $DVA, no?

1 · Reply

Mallingan Aug. 7 at 1:38 PM

$DVA

1 · Reply

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 20, 2025, 9:36 AM EDT - 5 days ago

DaVita: Aggressive Buybacks Despite Rising Cost Of Debt

Aug 5, 2025, 10:02 PM EDT - 19 days ago

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 5:15 PM EDT - 20 days ago

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 4:05 PM EDT - 20 days ago

DaVita Inc. 2nd Quarter 2025 Results

Jul 17, 2025, 5:37 PM EDT - 5 weeks ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jun 2, 2025, 12:15 PM EDT - 3 months ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

May 30, 2025, 2:35 PM EDT - 3 months ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 27, 2025, 11:30 AM EDT - 3 months ago

DaVita: International Expansion And Buybacks Will Boost Returns

May 20, 2025, 4:42 PM EDT - 3 months ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 9:05 AM EDT - 3 months ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 8:51 AM EDT - 3 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 12, 2025, 9:41 PM EDT - 3 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 5:37 PM EDT - 3 months ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 4:51 PM EDT - 3 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:05 PM EDT - 3 months ago

DaVita Inc. 1st Quarter 2025 Results

Apr 30, 2025, 11:00 AM EDT - 4 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 14, 2025, 7:35 AM EDT - 4 months ago

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:33 AM EDT - 4 months ago

Dialysis firm DaVita hit by ransomware attack

Mar 31, 2025, 7:35 AM EDT - 5 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

Mar 6, 2025, 10:00 AM EST - 6 months ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Feb 27, 2025, 9:00 AM EST - 6 months ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 19, 2025, 8:05 PM EST - 6 months ago

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 14, 2025, 1:01 PM EST - 6 months ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 8:16 AM EST - 6 months ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 13, 2025, 8:19 PM EST - 6 months ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:13 PM EST - 6 months ago

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 6:07 PM EST - 6 months ago

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 4:05 PM EST - 6 months ago

DaVita Inc. 4th Quarter 2024 Results

Jan 30, 2025, 11:55 AM EST - 7 months ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 28, 2025, 2:39 PM EST - 7 months ago

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

CI CVS HCA UHS

Jan 15, 2025, 9:05 AM EST - 7 months ago

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

Jan 9, 2025, 11:00 AM EST - 8 months ago

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

Nov 14, 2024, 2:19 PM EST - 10 months ago

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 12, 2024, 9:05 AM EST - 10 months ago

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

Nov 8, 2024, 4:33 PM EST - 10 months ago

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

Oct 29, 2024, 9:27 PM EDT - 10 months ago

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 4:23 PM EDT - 10 months ago

DaVita misses third-quarter profit estimates on higher costs

Oct 29, 2024, 4:05 PM EDT - 10 months ago

DaVita Inc. 3rd Quarter 2024 Results

Oct 28, 2024, 11:05 AM EDT - 10 months ago

DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program

Oct 23, 2024, 10:00 AM EDT - 10 months ago

DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024

Oct 22, 2024, 8:00 AM EDT - 10 months ago

DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program

Oct 17, 2024, 1:00 PM EDT - 11 months ago

DaVita Appoints Jessica Hergenreter as Chief People Officer

Oct 11, 2024, 3:58 PM EDT - 11 months ago

DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton

Oct 9, 2024, 1:47 PM EDT - 11 months ago

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

Oct 8, 2024, 1:38 PM EDT - 11 months ago

DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton

Sep 17, 2024, 9:00 AM EDT - 1 year ago

DaVita Accelerates Commitment to Community Health with Nationwide Tour

Sep 13, 2024, 8:00 AM EDT - 1 year ago

DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

DUK JNJ

Aug 20, 2024, 11:12 AM EDT - 1 year ago

DaVita: Scope For Valuation Upsides With Strengthening Economics (Rating Upgrade)

Yamauchii Aug. 24 at 9:22 AM

2 · Reply

ExoticDerivativesMgmt Aug. 23 at 11:25 AM

$DVA DaVita Inc is facing dialysis reimbursement pressure and labor cost inflation

0 · Reply

StocktwitsNews Aug. 22 at 3:27 AM

0 · Reply

TacoDrumpf Aug. 14 at 9:57 PM

$UNH Buffett should have kept some more $DVA Because next...Peoples will soon sell a 2nd kidney !! lol

0 · Reply

TacoDrumpf Aug. 14 at 9:53 PM

1 · Reply

BULLZ820 Aug. 12 at 10:49 PM

$DVA Davita needs to get everyone switched to Vafseo as soon as possible

0 · Reply

StockAutoPro Aug. 12 at 2:43 AM

$DVA: Buy target $127.05 Sell target $135.5 Strong earnings growth potential makes this DVA sector stock a lucrative long-term investment opportunity.

0 · Reply

StockAutoPro Aug. 11 at 5:04 PM

$DVA: Buy target $127.09 Sell target $135.54 Strong earnings report suggests continued growth for this leading biopharmaceutical company.

0 · Reply

NoRallyTil2026 Aug. 7 at 9:35 PM

$LLY $NVO $DVA Surely the struggles of $LLY and $NVO is bullish for $DVA, no?

1 · Reply

Mallingan Aug. 7 at 1:38 PM

$DVA

1 · Reply

JarvisFlow Aug. 7 at 1:14 PM

Barclays updates rating for DaVita ( $DVA ) to Equal-Weight, target set at 169 → 160.

0 · Reply

cheating_stock_investor Aug. 6 at 9:05 PM

$OM long as long as leslie is still the ceo. She was supposed to become a billionaire from this co and displace $DVA

0 · Reply

TSLA_S3XY Aug. 6 at 8:23 PM

$DVA Dead Company --- $CRMD

0 · Reply

Estimize Aug. 6 at 6:33 PM

$DVA reported 2.95 EPS and 3,187 revenue for Q2. http://www.estimize.com/intro/dva?chart=historical&metric_name=eps&utm_content=DVA&utm_med

0 · Reply

ZacksResearch Aug. 6 at 6:10 PM

$DVA plunges 10.1% despite earnings beat — what's the catch? 📉 DaVita posted a 9.3% EPS beat with a 6.1% revenue growth, yet shares are down as adjusted operating margin contracted 36 bps and normalized non-acquired treatment declined YoY. Understand the full picture here 👉 https://www.zacks.com/stock/news/2674071/davita-stock-down-despite-q2-earnings-beat-gross-margin-expands?cid=sm-stocktwits-2-2674071-body-6469&ADID=SYND_STOCKTWITS_TWEET_2_2674071_BODY_6469

0 · Reply

ZacksResearch Aug. 6 at 4:58 PM

$DVA beat earnings & boosted margins — so why’s the stock red? Q2 2025 came in strong with both earnings and revenue beating expectations, and gross margin expanding on solid core performance. Full breakdown here 👉 https://www.zacks.com/stock/news/2674071/davita-stock-down-despite-q2-earnings-beat-gross-margin-expands?cid=sm-stocktwits-2-2674071-teaser-6407&ADID=SYND_STOCKTWITS_TWEET_2_2674071_TEASER_6407

0 · Reply

Noname2022 Aug. 6 at 4:32 PM

$DVA $AKBA The market has spoken…

2 · Reply

Arcides Aug. 6 at 2:00 PM

$DVA another healthcare stock to trash..

0 · Reply

CustomCulture Aug. 6 at 1:10 AM

$DVA The report highlights DaVita's continued focus on patient care and disciplined financial execution, as stated by CEO Javier Rodriguez. The company held a conference call on August 5, 2025, to discuss these results, which is available on their investor relations website. Source. Impact on Companies like Akebia Therapeutics DaVita's strong financial performance, particularly in terms of revenue growth and profitability, can have several implications for companies that work with them, such as Akebia Therapeutics $AKBA

0 · Reply

CustomCulture Aug. 6 at 1:08 AM

$DVA The earnings report for DaVita Inc. released on August 5, 2025, for the second quarter ended June 30, 2025, showed the following key financial metrics: Consolidated Revenues: $3.380 billion Operating Income: $538 million Adjusted Operating Income: $551 million Diluted Earnings Per Share (EPS): $2.58 Adjusted Diluted EPS: $2.95 Operating Cash Flow: $324 million Free Cash Flow: $157 million Senior Notes Issued: $1.0 billion at 6.75% Share Repurchase: 3.1 million shares at an average price of $144.00 per share

0 · Reply

Noname2022 Aug. 6 at 12:08 AM

$CRMD $AKBA $DVA Brutal Davita earnings call… Still blaming COVID & Cybersecurity incidents for ”structural mistreatments” and increased mortality & hospitalizations… Hallmark of ”operational excellence”… Hope the unconfirmed LDO isnt them…partner carefully my friends…

11 · Reply

DerekQuick Aug. 5 at 6:09 PM

$UNH When markets pull back & rates are cut smart money finds safety in stocks like UnitedHealth. The sector relative to the S&P is near a 30 year low. Berkshire has been selling $DVA in the space which makes me think he is making room for UNH. Warrants would mean market would want it to go up so Buffett can take a major position, Waiting on filings but either way UNH doesn't need Buffett but wouldn't hurt.

1 · Reply

Market Cap	10.04B
Revenue (ttm)	12.82B
Net Income (ttm)	936.34M
EPS (ttm)	N/A
PE Ratio	14.07
Forward PE	12.59
Profit Margin	7.31%
Debt to Equity Ratio	-95.97

Volume	561,132
Avg Vol	847,114
Day's Range	N/A - N/A
Shares Out	71.50M
Stochastic %K	90%
Beta	1.09
Analysts	Sell
Price Target	$154.28